drugset
drugset / Trial / NCT00410501

Evaluation of Pharmacokinetic Interaction of Indacaterol With Ketoconazole in Healthy Adult Subjects

NCT00410501 ↗

Phase 1 Completed 20 enrolled Novartis
Non-randomizedCrossoverOpen-labelTreatment

Summary

This study will evaluate the interaction potential between indacaterol and ketoconazole (a potent CYP3A inhibitor) in healthy adult subjects.

Timeline

Start
2006-12
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Indacaterol Other / unclassified 300 ug Inhaled

Indications

No indication recorded.